{"nctId":"NCT00228917","briefTitle":"Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children","startDateStruct":{"date":"2005-06-16","type":"ACTUAL"},"conditions":["Whole Cell Pertussis","Tetanus","Hepatitis B","Diphtheria","Haemophilus Influenzae Type b","Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin"],"count":798,"armGroups":[{"label":"ACAC_Thailand Group","type":"EXPERIMENTAL","interventionNames":["Biological: Tritanrix-HepB/Hib-MenAC"]},{"label":"ACHibPS_Thailand Group","type":"EXPERIMENTAL","interventionNames":["Biological: Tritanrix-HepB/Hiberix","Biological: Mencevax-ACWY"]},{"label":"HibACPS_Thailand Group","type":"EXPERIMENTAL","interventionNames":["Biological: Tritanrix-HepB/Hib-MenAC","Biological: Mencevax-ACWY"]},{"label":"HibHibPS_Thailand Group","type":"EXPERIMENTAL","interventionNames":["Biological: Tritanrix-HepB/Hiberix","Biological: Mencevax-ACWY"]},{"label":"ACAC_Philippines Group","type":"EXPERIMENTAL","interventionNames":["Biological: Tritanrix-HepB/Hib-MenAC"]},{"label":"ACHibPS_Philippines Group","type":"EXPERIMENTAL","interventionNames":["Biological: Tritanrix-HepB/Hiberix","Biological: Mencevax-ACWY"]},{"label":"HibACPS_Philippines Group","type":"EXPERIMENTAL","interventionNames":["Biological: Tritanrix-HepB/Hib-MenAC","Biological: Mencevax-ACWY"]},{"label":"HibHibPS_Philippines Group","type":"EXPERIMENTAL","interventionNames":["Biological: Tritanrix-HepB/Hiberix","Biological: Mencevax-ACWY"]}],"interventions":[{"name":"Tritanrix-HepB/Hib-MenAC","otherNames":[]},{"name":"Tritanrix-HepB/Hiberix","otherNames":[]},{"name":"Mencevax-ACWY","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Written informed consent obtained from the parent or guardian of a healthy male or female child between, and including 15 and 18 months age (Philippines)/ 15 and 24 months age (Thailand) at the time of vaccination and who have previously received a 3-dose primary vaccination in the studies DTPwHB/HibMenAC-TT-004 (CPMS No. 759346/004) or DTPW-HBV=HIB-MENAC-TT-013 (eTrack No. 100791).\n\nExclusion Criteria:\n\n* Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine within 30 days preceding the vaccination, or planned use during the study period.\n* Chronic administration (\\> than 14 days) of immunosuppressants or other immune-modifying drugs within six months prior to vaccination.\n* Planned administration/administration of a vaccine not foreseen by the study protocol within 30 days of vaccination. Note: Oral poliovirus vaccine can be given concomitantly.\n* Booster vaccination against diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b (Hib) and/or meningococcal serogroups A and C disease, after the date of the study conclusion visit of the primary vaccination study.","healthyVolunteers":true,"sex":"ALL","minimumAge":"427 Days","maximumAge":"577 Days","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Subjects With Fever >39°C (Rectal Route).","description":"Among solicited general symptoms fever \\[defined as rectal temperature equal to or above (≥) 38 degrees Celsius (°C )\\] was assessed, post vaccination. Grade 3 fever = fever \\> 39.0 °C.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22","spread":null},{"groupId":"OG001","value":"8","spread":null},{"groupId":"OG002","value":"5","spread":null},{"groupId":"OG003","value":"3","spread":null},{"groupId":"OG004","value":"40","spread":null},{"groupId":"OG005","value":"24","spread":null},{"groupId":"OG006","value":"17","spread":null},{"groupId":"OG007","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any, Grade 3 and Related Solicited General Symptoms, Other Than Fever > 39.0°C","description":"Assessed solicited general symptoms were drowsiness, irritability, loss of appetite and fever \\[defined as axillary temperature equal to or above 38 degrees Celsius (°C)\\]. Any = occurrence of the symptom regardless of intensity grade. Grade 3 symptom = symptom that prevented normal activity. Related = symptom assessed by the investigator as related to the vaccination.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"113","spread":null},{"groupId":"OG001","value":"63","spread":null},{"groupId":"OG002","value":"41","spread":null},{"groupId":"OG003","value":"17","spread":null},{"groupId":"OG004","value":"53","spread":null},{"groupId":"OG005","value":"33","spread":null},{"groupId":"OG006","value":"23","spread":null},{"groupId":"OG007","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"3","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"2","spread":null},{"groupId":"OG007","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"110","spread":null},{"groupId":"OG001","value":"63","spread":null},{"groupId":"OG002","value":"41","spread":null},{"groupId":"OG003","value":"17","spread":null},{"groupId":"OG004","value":"16","spread":null},{"groupId":"OG005","value":"7","spread":null},{"groupId":"OG006","value":"4","spread":null},{"groupId":"OG007","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"149","spread":null},{"groupId":"OG001","value":"75","spread":null},{"groupId":"OG002","value":"53","spread":null},{"groupId":"OG003","value":"26","spread":null},{"groupId":"OG004","value":"116","spread":null},{"groupId":"OG005","value":"59","spread":null},{"groupId":"OG006","value":"39","spread":null},{"groupId":"OG007","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"5","spread":null},{"groupId":"OG004","value":"4","spread":null},{"groupId":"OG005","value":"2","spread":null},{"groupId":"OG006","value":"1","spread":null},{"groupId":"OG007","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"146","spread":null},{"groupId":"OG001","value":"74","spread":null},{"groupId":"OG002","value":"53","spread":null},{"groupId":"OG003","value":"26","spread":null},{"groupId":"OG004","value":"29","spread":null},{"groupId":"OG005","value":"15","spread":null},{"groupId":"OG006","value":"6","spread":null},{"groupId":"OG007","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"98","spread":null},{"groupId":"OG001","value":"46","spread":null},{"groupId":"OG002","value":"33","spread":null},{"groupId":"OG003","value":"15","spread":null},{"groupId":"OG004","value":"72","spread":null},{"groupId":"OG005","value":"40","spread":null},{"groupId":"OG006","value":"24","spread":null},{"groupId":"OG007","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"1","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"96","spread":null},{"groupId":"OG001","value":"46","spread":null},{"groupId":"OG002","value":"33","spread":null},{"groupId":"OG003","value":"15","spread":null},{"groupId":"OG004","value":"18","spread":null},{"groupId":"OG005","value":"10","spread":null},{"groupId":"OG006","value":"2","spread":null},{"groupId":"OG007","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"55","spread":null},{"groupId":"OG001","value":"24","spread":null},{"groupId":"OG002","value":"19","spread":null},{"groupId":"OG003","value":"7","spread":null},{"groupId":"OG004","value":"80","spread":null},{"groupId":"OG005","value":"41","spread":null},{"groupId":"OG006","value":"35","spread":null},{"groupId":"OG007","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"5","spread":null},{"groupId":"OG005","value":"2","spread":null},{"groupId":"OG006","value":"3","spread":null},{"groupId":"OG007","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"112","spread":null},{"groupId":"OG001","value":"57","spread":null},{"groupId":"OG002","value":"47","spread":null},{"groupId":"OG003","value":"18","spread":null},{"groupId":"OG004","value":"34","spread":null},{"groupId":"OG005","value":"21","spread":null},{"groupId":"OG006","value":"5","spread":null},{"groupId":"OG007","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any and Grade 3 Solicited Local Symptoms.","description":"Assessed solicited local symptoms were pain, redness and swelling. Any = occurrence of the symptom regardless of intensity grade. Grade 3 pain = pain that prevented normal activity. Grade 3 redness/swelling = redness/swelling spreading beyond 30 millimeters (mm) of injection site.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"168","spread":null},{"groupId":"OG001","value":"78","spread":null},{"groupId":"OG002","value":"55","spread":null},{"groupId":"OG003","value":"26","spread":null},{"groupId":"OG004","value":"151","spread":null},{"groupId":"OG005","value":"69","spread":null},{"groupId":"OG006","value":"49","spread":null},{"groupId":"OG007","value":"22","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57","spread":null},{"groupId":"OG001","value":"14","spread":null},{"groupId":"OG002","value":"12","spread":null},{"groupId":"OG003","value":"4","spread":null},{"groupId":"OG004","value":"42","spread":null},{"groupId":"OG005","value":"13","spread":null},{"groupId":"OG006","value":"22","spread":null},{"groupId":"OG007","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"99","spread":null},{"groupId":"OG001","value":"33","spread":null},{"groupId":"OG002","value":"33","spread":null},{"groupId":"OG003","value":"16","spread":null},{"groupId":"OG004","value":"40","spread":null},{"groupId":"OG005","value":"33","spread":null},{"groupId":"OG006","value":"21","spread":null},{"groupId":"OG007","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"1","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"1","spread":null},{"groupId":"OG007","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"95","spread":null},{"groupId":"OG001","value":"33","spread":null},{"groupId":"OG002","value":"33","spread":null},{"groupId":"OG003","value":"14","spread":null},{"groupId":"OG004","value":"51","spread":null},{"groupId":"OG005","value":"32","spread":null},{"groupId":"OG006","value":"21","spread":null},{"groupId":"OG007","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG002","value":"8","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"10","spread":null},{"groupId":"OG005","value":"6","spread":null},{"groupId":"OG006","value":"3","spread":null},{"groupId":"OG007","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any Unsolicited Adverse Events (AEs).","description":"An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms. Any was defined as the occurrence of any unsolicited AE regardless of intensity grade or relation to vaccination.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"64","spread":null},{"groupId":"OG001","value":"23","spread":null},{"groupId":"OG002","value":"24","spread":null},{"groupId":"OG003","value":"9","spread":null},{"groupId":"OG004","value":"53","spread":null},{"groupId":"OG005","value":"33","spread":null},{"groupId":"OG006","value":"16","spread":null},{"groupId":"OG007","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Serious Adverse Events (SAEs).","description":"Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/incapacity.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"2","spread":null},{"groupId":"OG005","value":"1","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":5,"n":398},"commonTop":["Pain","Pyrexia","Irritability","Somnolence","Decreased appetite"]}}}